Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630379 · ClinicalTrials.gov registry record · NA
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT04630379: Completed NA study, sponsored by Mayo Clinic.
NCT04630379 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04630379, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This trial assesses the quality of life in patients with high grade glioma and their caregivers using a questionnaire called the Beacon Patient Related Outcomes Quality of Life (PROQOL). Knowledge gained from this trial may help researchers find out if early integration of palliative care will lead to improvement in quality of life for both patients and caregivers.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- OTHER Supportive Care
- OTHER Palliative Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2020-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04630379
The ClinicalTrials.gov registry entry for NCT04630379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04630379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04630379 about?
NCT04630379 is a clinical study titled "Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers". This trial assesses the quality of life in patients with high grade glioma and their caregivers using a questionnaire called the Beacon Patient Related Outcomes Quality of Life (PROQOL). Knowledge gained from this trial may help researchers find out if early integration of palliative care will lead ...
What is the current status of trial NCT04630379?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-06-13. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04630379?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Supportive Care (OTHER), Palliative Therapy (OTHER).
Who is sponsoring clinical trial NCT04630379?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.